Atitaya Hitakarun

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

African American

Pluripotent Stem Cells

Diffuse Large B Cell Lymphoma

Top Venues

BMC complementary medicine and therapies

Scientific reports

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Suteema Sawadpongpan, Janejira Jaratsittisin, Atitaya Hitakarun, Sittiruk Roytrakul, Nitwara Wikan, Duncan R Smith
Investigation of the activity of baicalein towards Zika virus. BMC complementary medicine and therapies 23 (1) (2023)
Suteema Sawadpongpan, Janejira Jaratsittisin, Atitaya Hitakarun, Sittiruk Roytrakul, Nitwara Wikan, Duncan R Smith
Investigation of the activity of baicalein towards Zika virus. BMC complementary medicine and therapies 23 (1) (2023)
Suteema Sawadpongpan, Janejira Jaratsittisin, Atitaya Hitakarun, Sittiruk Roytrakul, Nitwara Wikan, Duncan R Smith
Investigation of the activity of baicalein towards Zika virus. BMC complementary medicine and therapies 23 (1) (2023)
Atitaya Hitakarun, Maia Kavanagh Williamson, Nathamon Yimpring, Wannapa Sornjai, Nitwara Wikan, Christopher J Arthur, Julien Francis Pompon, Andrew D Davidson, Duncan R Smith
Cell Type Variability in the Incorporation of Lipids in the Dengue Virus Virion. Viruses 14 (11) (2022)
Sarawut Khongwichit, Wannapa Sornjai, Kunlakanya Jitobaom, Mingkwan Greenwood, Michael P Greenwood, Atitaya Hitakarun, Nitwara Wikan, David Murphy, Duncan R Smith
A functional interaction between GRP78 and Zika virus E protein. Scientific reports 11 (1) (2021)
Chit Care, Wannapa Sornjai, Janejira Jaratsittisin, Atitaya Hitakarun, Nitwara Wikan, Kanokporn Triwitayakorn, Duncan R Smith
Discordant Activity of Kaempferol Towards Dengue Virus and Japanese Encephalitis Virus. Molecules (Basel, Switzerland) 25 (5) (2020)
Atitaya Hitakarun, Sarawut Khongwichit, Nitwara Wikan, Sittiruk Roytrakul, Sutee Yoksan, Supoth Rajakam, Andrew D Davidson, Duncan R Smith
Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus. Scientific reports 10 (1) (2020)